A randomised double-masked trial comparing the visual outcome after treatment with ranibizumab or bevacizumab in patients with neovascular age-related macular degeneration

Ilse Krebs*, Leopold Schmetterer, Agnes Boltz, Reinhard Told, Veronika Vécsei-Marlovits, Stefan Egger, Ulrich Schönherr, Anton Haas, Siamak Ansari-Shahrezaei, Susanne Binder

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

161 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A randomised double-masked trial comparing the visual outcome after treatment with ranibizumab or bevacizumab in patients with neovascular age-related macular degeneration'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Keyphrases